Psychotogenic properties of benzodiazepine receptor inverse agonists

Psychopharmacology

Volumn 156, Issue 1, 2001, Pages 1-13

  Sarter, M ^a   Bruno, J P ^a   Berntson, G G ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Amphetamine; Anxiety; Attention; Dopamine; FG 7142; Nucleus accumbens; Phencyclidine; Prefrontal cortex; Psychosis

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATROPINE; BENZODIAZEPINE RECEPTOR INVERSE STIMULATING AGENT; BETA CARBOLINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONIDINE; CLOZAPINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUMAZENIL; HALOPERIDOL; KETAMINE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PHENCYCLIDINE; PSYCHOSTIMULANT AGENT; SARMAZENIL; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; TROPISETRON; UNINDEXED DRUG;

ANXIETY; ATTENTION; BEHAVIOR; CHOLINERGIC ACTIVITY; COGNITION; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; MONKEY; NEUROCHEMISTRY; NEUROPHARMACOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT; REVIEW; SCHIZOPHRENIA;

ACETYLCHOLINE; CARBOLINES; CEREBRAL CORTEX; DOPAMINE; GABA ANTAGONISTS; HUMANS; LIMBIC SYSTEM; MALE; PSYCHOTIC DISORDERS; RECEPTORS, GABA-A; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0034938701     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100756     Document Type: Review

References (194)

1. Transmitter systems involved in the neural plasticity underlying increased anxiety and defense: Implications for understanding anxiety following traumatic stress
2. NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposure-implications for anxiety associated with posttraumatic stress disorder
3. Seizures associated with recreational drug abuse
4. "Cognitive dysmetria" as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical-cerebellar circuitry
5. Dissociation between cortical acetylcholine and accumbens dopamine release following systemic or intra-accumbens amphetamine administration
6. Role of locus coeruleus in emotional activation
7. Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and the medial prefrontal cortex of the rat
8. The effect of the β-carboline FG 7142 on the behaviour of male rats in a living cage: An ethological analysis of social and nonsocial behaviour
9. Reality testing and auditory hallucinations: A signal detection analysis
10. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia
11. Anxiety and cardiovascular reactivity: The basal forebrain cholinergic link
12. Influence of GABA on acetylcholine release from the guinea pig brain
13. A role for norepinephrine in stress-induced cognitive deficits: Alpha-1-adrenoceptor mediation in the prefrontal cortex
14. Amphetamine lowers extracellular GABA concentration in the ventral pallidum
15. Apomorphine decreases extra-cellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens
16. Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age
17. The anxiogenic β-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis
18. Information processing and attention dysfunctions in schizophrenia
19. Gating and habituation deficits in the schizophrenia disorders
20. Opposite links of positive and negative symptomatology with memory errors in schizophrenia
21. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence form a novel positron emission tomography method
22. Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders
23. Effects of an anxiogenic benzodiazepine receptor ligand on motor activity and dopamine release in nucleus accumbens and striatum in the rat
24. Inhibition of GABAergic transmission: Interactions with other transmitter systems
25. The schizophrenia ketamine challenge study debate
26. Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens
27. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys
28. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
29. A behavioural analysis of the delayed non-matching to position task: The effects of scopolamine, lesions of the fornix and the prelimbic region on mediating behaviours by rats
30. Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat
31. Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: Opposite effects of FG 7142 and lorazepam
32. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat
33. Disruption of selective attention in the rat following chronic d-amphetamine administration: Relationship to schizophrenic attention disorder
34. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine
35. The role of the amygdala in fear and anxiety
36. Cholinergic involvement in mental disorders
37. Dopamine in schizophrenia: A review and reconceptualization
38. Dopaminergic regulation of cortical acetylcholine release
39. Benzodiazepines and GABA hypotheses of schizophrenia
40. Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia - A study group report
41. Effects of repeated administration of amphetamine on behavioral vigilance: Evidence for "sensitized" attentional impairments
42. Diffuse transmission by acetylcholine in the CNS
43. The determinants of stress-induced activation of the prefrontal cortical dopamine system
44. Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors
45. Behavioral microanalysis of spatial delayed alternation performance: Rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide
46. Human experimental psychopharmacology of benzodiazepine receptor inverse agonists and antagonists
47. The effects of a benzodiazepine receptor antagonist β-carboline ZK 93426 on scopolamine-induced impairment on attention, memory and psychomotor skills
48. Animal models for the negative symptoms of schizophrenia
49. Central cholinergic systems and cognition
50. Cognitive factors in clinical anxiety: Potential relevance to therapy
51. Age-related attenuation of stimulated cortical acetylcholine release in basal forebrain-lesioned rats
52. Basal forebrain glutamatergic modulation of cortical acetylcholine release
53. 2A receptors and dopamine receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia
54. Increased dopamine and norepinephrine release in medial and prefrontal cortex induced by acute and chronic stress: Effects of diazepam
55. Elementary neuronal dysfunction in schizophrenia
56. Effects of flunitrazepam on memory and their reversal by two antagonists
57. Psychiatric sequelae of chronic exposure to organophosphorus insecticides
58. The role of acetylcholine within the medial prefrontal and posterior parietal cortices during sustained visual attention in rats
59. Sustained visual attentional performance-associated prefrontal neuronal activity: Evidence for cholinergic modulation
60. Ro15-4513, like anxiogenic β-carbolines, increase dopamine metabolism in the prefrontal cortex of the rat
61. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia
62. Gating of information flow within the limbic system and the pathophysiology of schizophrenia
63. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs
64. Dopamine release in the nucleus accumbens: The perspective from aberrations of consciousness in schizophrenia
65. Integrating schizophrenia
66. Increased distractibility in schizophrenic patients
67. Distinct features of seizures induced by cocaine and amphetamine analogs
68. Cortical cholinergic markers in schizophrenia
69. Evidence that GABA transmission mediates context-specific extinction of learned fear
70. Cardiovascular and somatic startle and defense: Concordant and disconcordant actions of benzodiazepine receptor agonists and inverse agonists
71. Cholinergic inputs to the medial prefrontal cortex mediate potentiation of the cardiovascular defensive response by the anxiogenic benzodiazepine receptor partial inverse agonist FG 7142
72. Basal forebrain in the context of schizophrenia
73. Benzodiazepine receptor inverse agonists and ingestive behavior: The palatability hypothesis
74. Effects of the benzodiazepine receptor inverse agonist Ro15-4513 on the ingestion of sucrose and sodium saccharin solutions: A microstructural analysis of licking behavior
75. Effects of benzodiazepine receptor ligands on the ingestion of sucrose, intralipid, and maltodextrin: An investigation using a microstructural analysis of licking behavior in a brief contact test
76. Operant performance and cortical acetylcholine release: Role of response rate, reward density, and non-contingent stimuli
77. Effects of local cholinesterase inhibition on acetylcholine release measured simultaneously in prefrontal and frontoparietal cortex
78. Increases in cortical acetylcholine release during sustained attention performance in rats
79. Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain
80. Blockade of FG 7142-induced increased dopamine utilization by the glycine/NMDA receptor antagonist (+)-HA 966
81. Anxiogenic β-carboline FG 7142 produces activation of noradrenergic neurons in specific brain regions of rats
82. GABA-immunoreactive synaptic boutons in the rat basal forebrain: Comparison of neurons that project to the neocortex with pallidosubthalamic neurons
83. Benzodiazepinmonotherapie bei akuten schizophrenien
84. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
85. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats
86. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion
87. 1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients
88. Effect of a pharmacological stressor on glutamate efflux in the prefrontal cortex
89. Cortical map reorganization enabled by nucleus basalis activity
90. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm
91. Amphetamine sensitization and amygdala kindling: Pharmacological evaluation of catecholaminergic and cholinergic mechanisms
92. The anxiogenic β-carboline FG-7142 increases in vivo and in vitro tyrosine hydroxylation in the prefrontal cortex
93. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
94. NMDA-sensitive glutamate antagonism: A human model for psychosis
95. Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies
96. Increased dopamine transmission in schizophrenia: Relationship to illness phases
97. From psychological stress to the emotions: A history of changing outlooks
98. Fear and the brain: Where have we been, and where are we going?
99. Emotion circuits in the brain
100. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia
101. Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunctions in neuronal regulation and plasticity
102. Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?
103. Kindling and withdrawal changes at the benzodiazepine receptor
104. The use of benzodiazepines in schizophrenia: A review
105. Behavioural vigilance in schizophrenia. Evidence for hyperattentional processing
106. Cognitive approaches to emotion and emotional disorders
107. Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in nucleus accumbens
108. Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands
109. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: Selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density
110. Disorders of attention and perception in early schizophrenia
111. Evidence that an accumbens to subpallidal GABAergic projection contributes to locomotor activity
112. Neural projections from nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: An anatomical and electrophysiological investigation in the rat
113. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
114. Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: Comparison to the striatum
115. Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands
116. Bidirectional modulation of cortical acetylcholine efflux by infusion of benzodiazepine receptor ligands into the basal forebrain
117. Stimulation of cortical acetylcholine efflux by FG 7142 measured with repeated microdialysis sampling
118. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release
119. The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia
120. Cholinergic enhancement of direction selectivity in the visual cortex of the cat
121. Dopamine and spatial working memory in rats and monkeys: Pharmacological reversal of stress-induced impairment
122. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys
123. Clozapine reverses the spatial working memory deficits induced by FG 7142 in monkeys
124. Signal detection indices in schizophrenics on a visual, auditory, and bimodal continuous performance test
125. Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis
126. Attentional performance in patients with psychotic and nonpsychotic major depression and schizophrenia
127. Repeated pre-treatment with amphetamine sensitizes increases in cortical acetylcholine release
128. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
129. Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks
130. Information processing and attentional functioning in the developmental course of schizophrenic disorders
131. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input
132. Dopaminergic reduction of excitability in nucleus accumbens neurons recorded in vitro
133. Dysfunction in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters
134. Atypical antipsychotics
135. FG 7142 selectively decreases nonpunished responding, but has no anxiogenic effects on time allocation in a conflict schedule
136. Effects of GABA compounds injected into the subpallidal regions of rat brain on nucleus accumbens evoked hyperactivity
137. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia
138. Operant behavior during sessions of intravenous cocaine is necessary and sufficient for phasic firing of signal nucleus accumbens neurons
139. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients
140. Does the reversal of the anticonflict effect of phenobarbital by beta-CCE and FG 7142 indicate benzodiazepine receptor-mediated anxiogenic properties?
141. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
142. Postmortem studies in schizophrenia
143. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
144. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to the prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms
145. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychosis: A retrospective study
146. Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication
147. Fear and anxiety induced by benzodiazepine receptor inverse agonists
148. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: Two sides of the same coin?
149. Cognitive functions of cortical ACh (acetylcholine): Lessons from studies on the trans-synaptic modulation of activated efflux
150. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis
151. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders
152. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brain stem afferents
153. Activating the damaged basal forebrain system: Tonic stimulation versus signal amplification
154. Behavioral facilitation and cognitive enhancement
155. Agonizing over antagonizing: What do benzodiazepine receptor antagonists demonstrate?
156. The cognitive neuroscience of sustained attention: Where top-down meets bottom-up
157. Stimulant-induced psychosis: An evaluation of animal models
158. The effects of increasing resource demand on vigilance performance in adults with schizophrenia or developmental attentional/learning disorders: A preliminary study
159. Top-down modulation of early sensory cortex
160. Neurochemical brain imaging investigations of schizophrenia
161. Attentional predictors of clinical change during neuroleptic treatment in schizophrenia
162. Cognitive alterations as markers of vulnerability to schizophrenia
163. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: A microdialysis and behavioral study
164. Kindling to the benzodiazepine receptor inverse agonist, FG 7142: Evidence for involvement of NMDA, but not non-NMDA, glutamatergic receptors
165. Attenuation of the bidirectional effects of chlordiazepoxide and FG 7142 on conditioned response suppression and associated cardiovascular reactivity by loss of cortical cholinergic inputs
166. Proconflict and electrocorticographic effects of drugs modulating GABAergic neurotransmission
167. Beta-CCE and FG 7142 increases defensiveness during intraspecies encounters in mice
168. GABAergic projection from the nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats
169. Selective increase in dopamine metabolism in the prefrontal cortex by the anxiogenic beta-carboline FG 7142
170. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization
171. Cholinergic hyperactivity and negative schizophrenic symptoms
172. Cholinergic hyperactivity and negative symptoms: Behavioral effects of physostigmine in normal controls
173. The cholinergic system in schizophrenia reconsidered
174. Anxiogenic properties of beta-CCE and FG 7142: A review of promises and pitfalls
175. Safety signal withdrawal: A behavioural paradigm sensitive to both "anxiolytic" and "nxiogenic" drugs under identical experimental conditions
176. Electrophysiological studies of acetylcholine and the role of the basal forebrain in the somatosensory cortex of the cat. II. Cortical neurons excited by somatic stimuli
177. Cortical acetylcholine and processing capacity: Effects of cortical cholinergic deafferentation on crossmodal divided attention in rats
178. Bidirectional modulation of basal forebrain NMDA receptor function differentially affects visual attentional but not visual discrimination performance
179. Efferent projections of the nucleus accumbens in the rat with special reference to subdivisions of the nucleus: Biotinylated dextran amine study
180. Input dysfunction in schizophrenia
181. Biochemical evidence for γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat
182. Critical review of GABA-ergic drugs in the treatment of schizophrenia
183. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenic patients
184. Learning-induced changes in auditory receptive fields
185. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: A search for common ground
186. Benzodiazepines in the treatment of schizophrenia: A review and reappraisal
187. Brain region effects of clozapine on amino acid and monoamine transmission
188. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens
189. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: The role of sensitization
190. Synaptic organization of basal forebrain cholinergic projection neurons
191. Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: A correlated light and electron microscopic double-immunolabeling study in rat
192. On the significance of subterritories in the "accumbens" part of the rat ventral striatum
193. Specificity in the efferent projections of the nucleus accumbens in the rat: Comparison of the rostral pole projection patterns with those of the core and shell
194. Direct comparison of projections from the central amygdaloid region and nucleus accumbens shell